MAKNEE is user-friendly and safe tool to assess the health and quality of the knee joint. MAKNEE measures kinetics, acoustics and temperatures which can help to diagnose multiple knee disorders – such as osteoarthritis – at different stages. Rapid diagnosis can hinder the progression of joint diseases, as different instructions can be given to slow down the prognosis, reducing the pain of the damaged joint. MAKNEE can also monitor the effectiveness of rehabilitation and predict the progression of joint diseases.
MAKNEE provides a safe and painless solution to evaluate the condition of the knee. The measuring device is placed firmly around the knee. Multiple easy tasks are then required to be performed by the patient, such as walking or bending the knee while sitting. During this test, the behaviors of the joints are evaluated and combined together to provide an overall assessment. Finally, the results of the analysis are provided through a software, giving an overview of the joint’s condition.
user-friendly and fast testing
diagnosis of multiple knee disorders
the device is external and does not harm the user
tested in clinical trials in hospitals
enables early diagnosis
Osteoarthritis is the most common articular disease in the world. While the pain mostly occurs during movements at early stages, the severity of the disorder increases with time and the pain becomes chronic, even during resting times of the joint. Eventually, the pain affects the life of the person affected, inducing an inability to perform daily activities, or at least reducing them. In Finland, osteoarthritis is the cause of 6% of invalidity pensions and leads to more than 600 000 medical visits annually. The cost of osteoarthritis to society has been estimated at nearly one billion euros a year.
While our main focus has been addressed to the diagnosis of osteoarthritis, clinical trials are planned to further validate the potential of MAKNEE to detect other joint diseases. Beside osteoarthritis, We estimate that our device can also detect anterior cruciate ligament damage, tendonitis, other ligaments injury, meniscal tears, etc.
MAKNEE was selected as a finalist in the Mass Challenge Switzerland and will participate in their accelerator. MassChallenge Switzerland has quickly become a leading driver of innovation and entrepreneurship in Europe by connecting startups with the experts and resources they need to grow.
MAKNEE's Jérôme Thevenot pitched the MAKNEE diagnostic technology in front of the Life Science judges and crowd. MAKNEE was given the first place due to preventative approach of the technology and the de-risk approach combining both animal and human trials.
MAKNEE's Jérôme Thevenot will be presenting in both Y science pitch competition and the Slush 100 pitching competition. You will also find our booth during Wednesday 5.12 at the location D29.
Jérôme Thevenot from MAKNEE will present his work Skin Temperature of the Patella Increases With Osteoarthritic Severity during the 2018 International Workshop on Osteoarthritis Imaging in France July 5-8.
MAKNEE project member Vesa Virtanen has been accepted to present his work Quantitative Assessment of Osteoarthritic Knee Instability: Comparison with Conventional Imaging Modalities, in the World Congress on Medical Physics & Biomedical Engineering in Prague June 3-8, 2018.
MAKNEE team is participating in the 2018 Upgraded Life Festival in Helsinki 31.5-1.6. We are excited to hear the events speakers and to talk with health care startup investors from the Nordics.
MAKNEE project member Bijay Shakya will present his work Detection of experimental cartilage damage with acoustic emission technique: An in vitro equine study, in the 34th World Veterinary Association Congress in Barcelona, on 5-8 May 2018.
MAKNEE project member Aleksei Tiulpin will present his work Acoustic Emissions and Kinetic Instability as New Clinical Biomarkers to Noninvasively Assess Knee Osteoarthritis, in the World Congress on Osteoarthritis on April 26-29, 2018 in Liverpool.
30.11-1.12 MAKNEE is participating in the 2017 Slush event. Slush is the most important startup event in Europe, bringing together over 2,000 startup companies and over one thousand investors.
MAKNEE has been chosen to participate in the fourth Nestholma accelerator program in Oulu. In this accelerator MAKNEE team is focusing on developing their value proposal and pitching skills.
location_on Oulu, Finland
smartphone 050 594 2879